Skip to main content
Rising heart drug prices led hospitals to cut utilization

Major price increases for nitroprusside and isoproterenol led 47 hospitals to reduce use of the medications, Cleveland Clinic researchers wrote in The New England Journal of Medicine. Use of nitroprusside, which treats dangerous elevations in blood pressure, fell 53% from 2012 to 2015 as prices rose thirtyfold, and use of isoproterenol, which plays a role in protecting the heart during surgery, fell 35% while the price per milligram jumped from $26.20 to $1,790.11.

Full Story: